A review article examines the evolving strategies and safety outcomes with allogeneic CAR T cell therapy.

Biopharma has been using lyophilization to stabilize injectables for more than 80 years, but the technique is capable of so much more.

Eli Lilly and Purdue University strengthen their ongoing drug discovery collaboration with further initiatives.

Biotech company Ethris explains the benefits and challenges of developing spray dried RNA vaccines.

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.

Carl June and UPenn researchers develop next generation CAR T cell therapy and demonstrate promising results in phase I trial.

Our latest roundup reports on Trump's “most favored nation” order, an EMA investigation into finasteride, and Novo Nordisk’s continued R&D for obesity

How new structural insights captured in high-resolution images could fuel next-gen therapies for TB.

We ask an expert about best practices for working with these complicated therapies.

Let us not forget the important role of academic spinouts in innovating across the modalities.